Article Figures & Data
Figures
- Figure 1.
Co—Primary End Point: Major Adverse Cardiac and Cerebrovascular Events at 540 Days
ASA, acetylsalicylic acid (aspirin); MACCE, major adverse cardiac and cerebrovascular event.
a±1.5 SE.
bHR, 0.303; 95% CI, 0.137 to 0.670; P =.002.
cHR, 0.407; 95% CI, 0.281 to 0.589; P <.001.
dHR, 0.591; 95% CI, 0.431 to 0.811; P <.001.
Adapted from Garratt KN et al. Prasugrel plus aspirin beyond 12 months is associated with improved outcomes after Taxus Liberté paclitaxel-eluting coronary stent placement. Circulation. 2015. E-pub ahead of print. DOI: 10.1161/CIRCULATIONAHA.114.013570. Accessed December 10, 2014. With permission from American Heart Association, Inc.
Tables
Tools
Table of contents
Cited By...
- No citing articles found.